跳至主要内容
临床试验/NCT01664013
NCT01664013Unknown4 期

The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients

Roongroj Bhidayasiri1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2012年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
20
试验地点
1
主要终点
To investigate the change of quality of life of cervical dystonia patients after botulinum toxin treatment measured by CDQ-24.

研究概览

简要总结

The purpose of this study is to investigate the impact of botulinum toxin treatment in quality of life(QoL) in cervical dystonia patients

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • aged ≥ 18 years to 75 years
  • Subjects requiring treatment for a clinical diagnosis of cervical dystonia
  • Willing to provide written informed consent before any study-related procedures.

排除标准

  • Patients with pure anterocollis
  • Patients with an anaphlyactic response history to botulinum toxin type A.
  • Patients who have been treated with botulinum toxin type A within 3 month.
  • Females who are pregnant, planning pregnancy, unable to use contraception or lactating.
  • Any medical condition that may put the subject at increased risk with exposure to botulinum toxin at the discrimination of investigators.

研究组 & 干预措施

Neuronox

Experimental

Neuronox® is a botulinum toxin type A (BoNT/A) product developed by Medytox Inc. (Medytox) of Korea. Neuronox® was first approved by the Korean Food and Drug Administration in 2006, and by Thai Food and Drug Administration in 2008.

干预措施: Nuronox (Drug)

结局指标

主要结局

To investigate the change of quality of life of cervical dystonia patients after botulinum toxin treatment measured by CDQ-24.

时间窗: 6 weeks

To investigate the change of quality of life of cervical dystonia patients from baseline at 6 weeks after botulinum toxin treatment measured by CDQ-24.

次要结局

  • To investigate the change of QoL of cervical dystonia patientsafter botulinum toxin treatment measured by SF-36 (Thai version)(6 weeks)
  • To Investigate the change of symptom after botulinum toxin treatment measured by TWSTRS score(6 weeks)

研究者

发起方
Roongroj Bhidayasiri
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Roongroj Bhidayasiri

Associate Professor

Chulalongkorn University

研究点 (1)

Loading locations...

相似试验